Skip to main content
. Author manuscript; available in PMC: 2012 Aug 13.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Oct 11;19(12):3150–3156. doi: 10.1158/1055-9965.EPI-10-0763

Table 1.

Characteristics of non-Hispanic white participants in Los Angeles and Chinese participants in Shanghai

Los Angeles County
Shanghai
Cases, n (%) Controls, n (%) Cases, n (%) Controls, n (%)
Number of participants 509 (100) 602 (100) 541 (100) 535 (100)
Reference age, y
 Mean ± SD 54.4 ± 7.1 54.4 ± 8.0 60.7 ± 9.8 61.8 ± 10.0
 Median 56 56 63 64
 ≤45 53 (10.4) 74 (12.3) 51 (9.4) 44 (8.2)
 45—49 58 (11.4) 70 (11.6) 31 (5.7) 17 (3.2)
 50—54 94 (18.5) 112 (18.6) 38 (7.0) 27 (5.0)
 55—59 155 (30.5) 170 (28.2) 44 (8.1) 64 (12.0)
 60+ 149 (29.3) 176 (29.2)
 60—64 141 (26.1) 120 (22.4)
 65+ 236 (43.6) 263 (49.2)
Sex
 Male 401 (78.8) 485 (80.6) 429 (79.3) 412 (77.0)
 Female 108 (21.2) 117 (19.4) 112 (20.7) 123 (23.0)
Education
 Elementary or below / / 181 (33.5) 176 (32.9)
 Middle school / / 158 (29.2) 154 (28.8)
 High school / / 93 (17.2) 90 (16.8)
 High school or below 169 (33.2) 140 (23.3)
 1–3 years of college 167 (32.8) 188 (31.2) 70 (12.9) 76 (14.2)
 College graduate 173 (34.0) 274 (45.5) 39 (7.2) 39 (7.3)
Pχ2(2df) < 0.0001 Pχ2(4df) = 0.98
Cigarette smoking
 Never 95 (18.7) 237 (39.4) 182 (33.6) 238 (44.5)
 Former 193 (37.9) 259 (43.0) 76 (14.0) 86 (16.1)
 Current 221 (43.4) 106 (17.6) 283 (52.3) 211 (39.4)
Pχ2(2df) < 0.0001 Pχ2(2df) < 0.0001
NSAID use
 Nonusers 313 (61.5) 355 (59.0) / /
 1-<1,441 pills over lifetime 87 (17.1) 116 (19.3) / /
 ≥1,441 pills over lifetime 103 (20.2) 129 (21.4) / /
 Unknown 6 (1.2) 2 (0.3) / /
Pχ2(3df) = 0.27
Stage/grade
 Tis 30 (5.9) / / /
 Ta/G1 112 (22.0) / / /
 Ta/G2 172 (33.8) / / /
 Ta/G3—4 28 (5.5) / / /
 Ta/unknown 2 (0.4) / / /
 T1/G1 8 (1.6) / / /
 T1/G2 41 (8.1) / / /
 T1/G3—4 53 (10.4) / / /
 T2–4/G1 2 (0.4)
 T2–4/G2 8 (1.6) / / /
 T2–4/G3—4 48 (9.4) / / /
 Unknown 5 (1.0) / / /
 Ta 314 (61.7)
 Other 190 (37.3)
 Unknown 5 (1.0)
Stage/grade
 Ta/G1–2a 284 (55.8) / / /
 All other stage/gradeb 218 (42.8) / / /
 Unknown 7 (1.4) / / /
a

“Low probability of progression” as defined by Kiemeney et al. (14).

b

“High probability of progression” as defined by Kiemeney et al. (14).